PARIS, May 12 (Reuters) - U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development, ahead of the start of this year's annual 'Choose France' business summit. ($1 = 0.9286 euros) (Reporting by Sudip Kar-Gupta and Elizabeth Pineau; Editing by Hugh Lawson)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.55 USD | +0.20% | +6.22% | +2.64% |
Jun. 05 | Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment | DJ |
Jun. 05 | Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.64% | 167B | |
+42.69% | 750B | |
+34.11% | 606B | |
-6.87% | 356B | |
+18.74% | 326B | |
+6.76% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+6.72% | 165B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer announces 500 million euros investment in France